These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 17908924
1. Disposition and metabolism of [14C]brasofensine in rats, monkeys, and humans. Zhu M, Whigan DB, Chang SY, Dockens RC. Drug Metab Dispos; 2008 Jan; 36(1):24-35. PubMed ID: 17908924 [Abstract] [Full Text] [Related]
2. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys. Siefert HM, Maruhn D, Maul W, Förster D, Ritter W. Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211 [Abstract] [Full Text] [Related]
3. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T, Hayashi T, Okita A, Morino A. Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298 [Abstract] [Full Text] [Related]
5. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs. Halpin RA, Geer LA, Zhang KE, Marks TM, Dean DC, Jones AN, Melillo D, Doss G, Vyas KP. Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947 [Abstract] [Full Text] [Related]
7. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey. Adams WJ, McGovren JP, Dalm EA, Brewer JE, Hosley JD. Cancer Res; 1989 Nov 15; 49(22):6328-36. PubMed ID: 2529962 [Abstract] [Full Text] [Related]
10. Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys. Tan EY, Hartmann G, Chen Q, Pereira A, Bradley S, Doss G, Zhang AS, Ho JZ, Braun MP, Dean DC, Tang W, Kumar S. Drug Metab Dispos; 2010 Mar 15; 38(3):459-73. PubMed ID: 20016052 [Abstract] [Full Text] [Related]
11. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes. Kalgutkar AS, Hatch HL, Kosea F, Nguyen HT, Choo EF, McClure KF, Taylor TJ, Henne KR, Kuperman AV, Dombroski MA, Letavic MA. Biopharm Drug Dispos; 2006 Nov 15; 27(8):371-86. PubMed ID: 16944451 [Abstract] [Full Text] [Related]
12. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys. Yamada Y, Endo M, Kohno M, Otsuka M, Takaiti O. Arzneimittelforschung; 1992 Apr 15; 42(4):499-506. PubMed ID: 1642673 [Abstract] [Full Text] [Related]
13. Biodisposition studies with the acyl-coenzyme A: cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide, CI-976. Woolf TF, Black A, Shum YY, McNally W, Lee H, Chang T. Drug Metab Dispos; 1993 Apr 15; 21(6):1112-8. PubMed ID: 7905392 [Abstract] [Full Text] [Related]
14. Disposition of [14C]avitriptan in rats and humans. Marathe PH, Greene DS, Barbhaiya RH. Drug Metab Dispos; 1997 Jul 15; 25(7):881-8. PubMed ID: 9224783 [Abstract] [Full Text] [Related]
15. Single-dose pharmacokinetics and metabolism of [14C]remofovir in rats and cynomolgus monkeys. Lin CC, Xu C, Zhu N, Lourenco D, Yeh LT. Antimicrob Agents Chemother; 2005 Mar 15; 49(3):925-30. PubMed ID: 15728885 [Abstract] [Full Text] [Related]
16. Disposition and metabolism of prinomide in laboratory animals. Egger H, Itterly W, John V, Rodebaugh R, Shimanskas C, Stancato F, Kapoor A. Drug Metab Dispos; 1988 Mar 15; 16(4):568-75. PubMed ID: 2903025 [Abstract] [Full Text] [Related]
17. Disposition and metabolism of amosulalol hydrochloride, a new combined alpha- and beta-adrenoceptor blocking agent, in rats, dogs and monkeys. Sasaki H, Kamimura H, Kaniwa H, Kawamura S, Takaichi M, Yokoshima T. Xenobiotica; 1984 Aug 15; 14(8):621-31. PubMed ID: 6149657 [Abstract] [Full Text] [Related]